DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

8.33 0.08 (0.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BCRX $8.33 0.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.26
Previous Close $8.25
Daily Range $7.90 - $8.56
52-Week Range $1.42 - $13.33
Market Cap $494.7M
P/E Ratio -16.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,315,788
Average Daily Volume 931,594
Current FY EPS -$0.75





BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website:

News & Commentary Rss Feed

BioCryst Pharmaceuticals Q4 Loss Shrinks 51% on Higher Collaborative Revenue

BioCryst Pharmaceuticals reports a big jump in revenue amid tame expense growth, but investors will want to note the company's current cash balance and expected burn rate for 2014.

BioCryst Pharmaceuticals Is Now Oversold (BCRX)

'Mad Money' Lightning Round: Hess Is Undervalued

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's "Dead Cat Bounce" Stock

UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectation

UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectations for Oral HAE Drug

Benzinga's Top Initiations

BioCryst Pharmaceuticals: 3 Different Insiders Have Sold Shares This Month

Avanir Pharmaceuticals (AVNR) Jumps: Stock Moves 11.7% Higher - Tale of the Tape

BioCryst Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

BioCryst Pharmaceuticals (BCRX) Jumps: Stock Rises 10.5% - Tale of the Tape

Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session - Tale of the Tape

See More BCRX News...

BCRX's Top Competitors

BCRX $8.33 (0.97%)
Current stock: BCRX
AMGN $115.00 (1.48%)
Current stock: AMGN
GILD $68.17 (2.07%)
Current stock: GILD
BIIB $285.49 (2.14%)
Current stock: BIIB